Skip to main content

Table 3 Regorafenib related ADRs in 47 patients

From: Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study

Item

Grade 3–4

Number of cases

(%)

HFS

2

3.51

Haemorrhage

1

1.75

Nausea

0

0.00

Dysphonia

0

0.00

Weakness

0

0.00

Diarrhoea

1

1.75

Hypertension

1

1.75

Arthralgia

0

0.00

Urinary-tract infection

0

0.00

Vomit

0

0.00

Rash

0

0.00

Upper respiratory tract infection

0

0.00

Loss of appetite

0

0.00

Lose weight

0

0.00

Stomach ache

1

1.75

Myocardial ischemia

0

0.00

  1. The result of this table is the highest level of corresponding symptoms, and the percentage denominator is 47
  2. HFS hand-foot syndrome